Old Web
English
Sign In
Acemap
>
Paper
>
Alirocumab offers superior benefits to usual care in treating high-risk patients with type 2 diabetes
Alirocumab offers superior benefits to usual care in treating high-risk patients with type 2 diabetes
2020
Meletios A. Dimopoulos
Jacob Laubach
Maria Asuncion Echeveste Gutierrez
Norbert Grzasko
Craig C. Hofmeister
Jesús F. San Miguel
Shaji Kumar
Richard Labotka
Vickie Lu
Deborah Berg
Catriona Byrne
Zhaoyang Teng
Guohui Liu
Helgi van de Velde
Paul G. Richardson
Keywords:
Type 2 diabetes
Alirocumab
usual care
Intensive care medicine
high risk patients
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]